A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
T 3 Reverse, LC/MS/MS
Test CodeAlias/See Also
LAB9721
CPT Codes
<p>84482</p>
Preferred Specimen
Specimen Type: Serum
Collection Container/Type
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
- Allow blood to clot at room temperature for 30 minutes.
- Centrifuge and separate the serum from cells immediately.
- Alternatively, collect blood in a serum separator tube (SST), allow to clot at room temperature, centrifuge, and remove from gel within 24 hours.
Specimen Type: Plasma
Collection Container/Type
Preferred: Green top (Sodium heparin)
Acceptable: Lavender top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Minimum Volume
0.3 mL
Other Acceptable Specimens
Instructions
Serum: Allow blood to clot at room temperature for 30 minutes. Centrifuge to separate serum from the cells within 24 hours of collection and immediately pour serum into a plastic transport tube.
Plasma: Centrifuge to separate plasma from the cells within 24 hours of collection and immediately pour plasma into a plastic transport tube.
Transport Container
Transport Temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Unseparated serum (>48 hours on clot) • Serum in Serum Separator Tube (SST ®) not separated from the gel within 24 hours
Methodology
Chromatography/Mass Spectrometry
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Report Available
2-4 days
Reference Range
Clinical Significance
The process of 5'-monodeiodination that converts T4 to T3, and rT3 to diiodothyronine (DTT) is inhibited in a wide variety of conditions, collectively referred to as nonthyroidal illnesses (NTI) or the 'euthyroid sick' state. These conditions include fasting, malnutrition, poorly controlled diabetes mellitus, trauma, surgery, and systemic illness. Consequently, in patients with NTI the serum T3 level typically decreases, and the rT3 often, but not always, increases.
Performing Laboratory
Quest Diagnostics Nichols Institute 14225 Newbrook Drive Chantilly, VA 20153
Last Updated: February 17, 2023